Sumatriptan Tablet
Product Images NDC 16714-798

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 16714-798). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)
FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig2)

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig2)
Estimated Probability of Remedication or Rescue is provided in the text. The rest of the text is not readable and appears to be a mix of letters, symbols, and numbers.*
FDA Label Image

Package Label-principal Display Panel (25 mg Blister Carton (9 Unit-dose))

Package Label-principal Display Panel (25 mg Blister Carton (9 Unit-dose))
This is a pharmaceutical label for Sumatriptan Tablets, USP, containing 25 mg of Sumatriptansucinate USP. The package contains 2 strips of 5 Unit-dose tablets totaling 10 tablets and is manufactured by Northstar. The NDC number is 16714-796-01 and the product expiry date is August 2021.*
FDA Label Image

Package Label-principal Display Panel (50 mg Blister Carton (9 Unit-dose))

Package Label-principal Display Panel (50 mg Blister Carton (9 Unit-dose))
This is a description of Sumatriptan Tablets with a dosage of 50 mg. The tablets should be swallowed whole and stored in a cool place. The medicine is manufactured by Northstar Bx LLC and each package contains 9 unit-dose tablets. The tablets are used for migraines and each contains 70 mg of sumatriptan succinate USP which is equivalent to 50mg of sumatriptan. The NDC number is 16714-797-01.*
FDA Label Image

Package Label-principal Display Panel (100 mg Blister Carton (9 Unit-dose))

Package Label-principal Display Panel (100 mg Blister Carton (9 Unit-dose))
This appears to be a description of Sumatriptan Tablets, USP manufactured by Aurbindo Prarma Limited for NortstarRx. The tablets come in unit-dose packaging and each tablet contains 140 mg sumatriptan succinate USP equivalent to 100 mg of sumariptan. The text also includes dosage instructions and storage details. The location of the manufacturer and distributor are mentioned as Memphis, TN, and Hyderabad, India, respectively.*
FDA Label Image

Chemical Structure (Sumatriptan Str)

Chemical Structure (Sumatriptan Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.